Vor Biopharma Price Target Maintained With a $17.50/Share by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/quote/VOR/analyst-ratings
(END) Dow Jones Newswires
December 10, 2024 12:21 ET (17:21 GMT)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial